MARC Record from Library of Congress

LEADER: 02757cam a22004097a 4500
001 2010516097
003 DLC
005 20120328083608.0
008 100924s2010 sz a b i000 0 eng d
010 $a 2010516097
020 $a924154788X (spiral bound : pbk.)
020 $a9789241547888 (spiral bound : pbk.)
035 $a(OCoLC)ocn603068849
040 $aYDXCP$cYDXCP$dTPH$dCUX$dHPH$dORU$dGUA$dIXA$dUBY$dDLC
042 $alccopycat
050 00 $aRM171$b.S384 2010
060 14 $aWB 356$bS433 2010
082 00 $a615.3/9$223
245 00 $aScreening donated blood for transfusion-transmissible infections :$brecommendations.
260 $aGeneva :$bWorld Health Organization,$cc2010.
300 $a67 p. :$bill. ;$c30 cm.
504 $aIncludes bibliographical references (p. 60-62).
530 $aAlso available via the World Wide Web.
505 0 $aIntroduction -- National blood screening programme for transfusion-transmissible infections -- Screening essays -- Screening for transfusion-transmissible infections -- Blood screening, quarantine and release -- Confirmatory testing and blood donor management -- Quality systems in blood screening.
520 $a"The establishment of systems to ensure that all donated blood is screened for transfusion-transmissible infections is a core component of every national blood programme. Globally, however, there are significant variations in the extent to which donated blood is screened, the screening strategies adopted and the overall quality and effectiveness of the blood screening process. As a result, in many countries the recipients of blood and blood products remain at unacceptable risk of acquiring life-threatening infections that could easily be prevented. These recommendations are designed to support countries in establishing effective national programmes to ensure 100% quality-assured screening of donated blood for transfusion-transmissible infections. In countries where systems are not yet fully in place, the recommendations will be helpful in instituting a step-wise process to implement them."--Publisher's description.
650 0 $aBlood$xTransfusion$xComplications.
650 0 $aBlood$xTransfusion$xSafety measures.
650 0 $aBlood donors$xDiseases.
650 12 $aBlood Transfusion$xadverse effects.
650 12 $aBlood Transfusion$xstandards.
650 12 $aDisease Transmission, Infectious$xprevention & control.
650 12 $aDonor Selection$xstandards.
650 22 $aNational Health Programs$xstandards.
710 2 $aWorld Health Organization.
856 41 $uwww.who.int/.../bloodsafety/ScreeningDonatedBloodforTransfusion.pdf
856 41 $uhttp://www.searo.who.int/LinkFiles/BCT_WHO-Recommendations-09.pdf
856 41 $uhttp://bibpurl.oclc.org/web/39863